Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Catalano

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Biometrics|September 2, 2005
Quantitative risk assessment for multivariate continuous outcomes with application to neurotoxicology: the bivariate caseZi-Fan Yu, Paul J Catalano
International Journal of Radiation Oncology, Biology, Physics|March 11, 2015
Local therapies for brain metastases, competing risks, and overall survivalNils D Arvold, Paul J Catalano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2004
A rose, is a rose, is a rose...or notAl B Benson, Paul J Catalano
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 13, 2012
On determining the BMD from multiple outcomes in developmental toxicity studies when one outcome is intentionally missingJulie S Najita, Paul J Catalano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2026
Reply to: "Limitations in Study Design and Stratification in Phase II Stereotactic Radiosurgery Trial for Small Cell Lung Cancer Brain Metastases," "Radiosurgery for Small Cell Lung Cancer Brain Metastases: Comparing the JLGK0901 and BWH/DFCI Trials," and "Expanding Indications for Stereotactic Radiosurgery in Small Cell Lung Cancer With Brain Metastases"Ayal A Aizer, Paul J Catalano, Rifaquat Rahman
Journal of the Royal Statistical Society. Series C, Applied Statistics|April 2, 2010
A Novel Application of a Bivariate Regression Model for Binary and Continuous Outcomes to Studies of Fetal ToxicityJulie S Najita, Yi Li, Paul J Catalano
Journal of the National Cancer Institute|July 2, 2026
Beyond R2: Assessing quality of trial level surrogate endpoints in colorectal cancerNatalie Heater, Paul J Catalano, Al B Benson
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 18, 2008
A simulation study of quantitative risk assessment for bivariate continuous outcomesZi-Fan Yu, Paul J Catalano, Paul J Catzlano
Journal of the National Cancer Institute|May 16, 2002
High rate of consent to bank biologic samples for future research: the Eastern Cooperative Oncology Group experienceThomas Malone, Paul J Catalano, Peter J O'Dwyer, et al.
Biometrics|March 23, 2004
Exact analysis of dose response for multiple correlated binary outcomesKaren E Han, Paul J Catalano, Pralay Senchaudhuri, et al.
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Biometrics|September 2, 2005
Quantitative risk assessment for multivariate continuous outcomes with application to neurotoxicology: the bivariate caseZi-Fan Yu, Paul J Catalano
International Journal of Radiation Oncology, Biology, Physics|March 11, 2015
Local therapies for brain metastases, competing risks, and overall survivalNils D Arvold, Paul J Catalano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2004
A rose, is a rose, is a rose...or notAl B Benson, Paul J Catalano
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 13, 2012
On determining the BMD from multiple outcomes in developmental toxicity studies when one outcome is intentionally missingJulie S Najita, Paul J Catalano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2026
Reply to: "Limitations in Study Design and Stratification in Phase II Stereotactic Radiosurgery Trial for Small Cell Lung Cancer Brain Metastases," "Radiosurgery for Small Cell Lung Cancer Brain Metastases: Comparing the JLGK0901 and BWH/DFCI Trials," and "Expanding Indications for Stereotactic Radiosurgery in Small Cell Lung Cancer With Brain Metastases"Ayal A Aizer, Paul J Catalano, Rifaquat Rahman
Journal of the Royal Statistical Society. Series C, Applied Statistics|April 2, 2010
A Novel Application of a Bivariate Regression Model for Binary and Continuous Outcomes to Studies of Fetal ToxicityJulie S Najita, Yi Li, Paul J Catalano
Journal of the National Cancer Institute|July 2, 2026
Beyond R2: Assessing quality of trial level surrogate endpoints in colorectal cancerNatalie Heater, Paul J Catalano, Al B Benson
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 18, 2008
A simulation study of quantitative risk assessment for bivariate continuous outcomesZi-Fan Yu, Paul J Catalano, Paul J Catzlano
Journal of the National Cancer Institute|May 16, 2002
High rate of consent to bank biologic samples for future research: the Eastern Cooperative Oncology Group experienceThomas Malone, Paul J Catalano, Peter J O'Dwyer, et al.
Biometrics|March 23, 2004
Exact analysis of dose response for multiple correlated binary outcomesKaren E Han, Paul J Catalano, Pralay Senchaudhuri, et al.
Pageof 17